Peptide Directory

A modified fragment of human growth hormone studied for fat metabolism and weight loss without affecting blood sugar.

A pentadecapeptide derived from gastric juice, studied for its tissue-healing and anti-inflammatory properties.

A growth hormone-releasing hormone analog that stimulates GH release with a shorter duration than the DAC variant.

A long-acting GHRH analog that provides sustained GH elevation due to the Drug Affinity Complex modification.

A neuropeptide studied for its role in promoting deep, restorative (delta wave) sleep.

A synthetic tetrapeptide based on epithalamin, studied for telomerase activation and potential anti-aging effects.

A copper-binding tripeptide with research suggesting skin regeneration, wound healing, and anti-aging properties.

A selective growth hormone secretagogue that stimulates GH release with minimal impact on cortisol and prolactin.

A melanocortin receptor agonist studied for sexual dysfunction. Acts on the central nervous system rather than vascular system.

An investigational triple-agonist peptide targeting GIP, GLP-1, and glucagon receptors for weight management.

A GLP-1 receptor agonist used for type 2 diabetes and weight management. Reduces appetite and slows gastric emptying.

A synthetic peptide of thymosin beta-4, researched for wound healing, tissue repair, and anti-inflammatory effects.

An immune-modulating peptide that enhances T-cell function and immune surveillance.

A dual GIP/GLP-1 receptor agonist for type 2 diabetes and weight management with potent appetite suppression.